New insights into the pharmacokinetics of intravenous busulfan in children with sickle cell anemia undergoing bone marrow transplantation

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|62|4|680-686

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.4, 2015-04, pp. : 680-686

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non‐total body irradiation myeloablative conditioning with intravenous busulfan and cyclophosphamide is feasible in bone marrow transplantation for osteopetrosis

By  

PEDIATRIC TRANSPLANTATION, Vol. 1397-3142, Iss. 7, 2015-11 ,pp. : 801-802

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical comparison of weight‐ and age‐based strategy of dose administration in children receiving intravenous busulfan for hematopoietic stem cell transplantation

By  

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 3, 2015-05 ,pp. : 307-315

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bone loss and vitamin D deficiency in children undergoing hematopoietic cell transplantation

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 4, 2015-04 ,pp. : 687-692

John Wiley & Sons Inc

Access to resources Recommend Favorite

Growth of lung function in children with sickle cell anemia

By  

PEDIATRIC PULMONOLOGY, Vol. 43, Iss. 11, 2008-11 ,pp. : 1061-1066

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cytomegalovirus gB Genotype Distribution in Mexican Children Undergoing Allogeneic Bone Marrow Transplantation

By  

Intervirology, Vol. 55, Iss. 4, 2011-07 ,pp. : 318-320

Karger

Access to resources Recommend Favorite